Key result
Glibenclamide impaired skeletal muscle blood flow in male (↓28%) and female (↓33%) rats, with females also demonstrating impaired diffusive O2 transport and a faster fall in interstitial PO2.
Why the study?
Sex differences in cardiac K ATP channel function exist, but potential sex differences in vascular K ATP channel function remain unknown.
Does glibenclamide impair skeletal muscle blood flow and O2 delivery differently based on sex and ovarian status in rats?
Does glibenclamide impair skeletal muscle blood flow and O2 delivery differently based on sex and ovarian status in rats?
Sex differences exist in vascular KATP channel function, with glibenclamide impairing skeletal muscle blood flow and oxygen delivery in male and ovary-intact female rats, but not ovariectomized females, suggesting potential sex-specific adverse effects of sulfonylureas on exercise tolerance.
May warrant sex-specific monitoring with sulphonylureas; leaves open clinical relevance of vascular KATP differences.
Key points Inhibition of pancreatic ATP‐sensitive K + (K ATP ) channels is the intended effect of oral sulphonylureas to increase insulin release in diabetes. However, pertinent to off‐target effects of sulphonylurea medication, sex differences in cardiac K ATP channel function exist, whereas potential sex differences in vascular K ATP channel function remain unknown. In the present study, we assessed vascular K ATP channel function (topical glibenclamide superfused onto fast‐twitch oxidative skeletal muscle) supporting blood flow and interstitial O 2 delivery‐utilization matching ( is ) during twitch contractions in male, female during pro‐oestrus and ovariectomized female (F+OVX) rats. Glibenclamide decreased blood flow (convective O 2 transport) and interstitial in male and female, but not F+OVX, rats. Compared to males, females also demonstrated impaired diffusive O 2 transport and a faster fall in interstitial . Our demonstration, in rats, that sex differences in vascular K ATP channel function exist support the tentative hypothesis that oral sulphonylureas may exacerbate exercise intolerance and morbidity, especially in premenopausal females. Abstract Vascular ATP‐sensitive K + (K ATP ) channels support skeletal muscle blood flow ( ), interstitial O 2 delivery ( )‐utilization ( ) matching (i.e. interstitial‐myocyte O 2 flux driving pressure; is ) and exercise tolerance. Potential sex differences in skeletal muscle vascular K ATP channel function remain largely unexplored. We hypothesized that local skeletal muscle K ATP channel inhibition via glibenclamide superfusion (5 mg kg –1 GLI; sulphonylurea diabetes medication) in anaesthetized female Sprague–Dawley rats, compared to males, would demonstrate greater reductions in contracting (1 Hz, 7 V, 180 s) fast‐twitch oxidative mixed gastrocnemius (97% type IIA+IID/X+IIB) (15 μm microspheres) and is (phosphorescence quenching), resulting from more compromised convective ( ) and diffusive ( ) O 2 conductances. Furthermore, these GLI‐induced reductions in ovary‐intact females measured during pro‐oestrus would be diminished following ovariectomy (F+OVX). GLI similarly impaired mixed gastrocnemius in both males (↓28%) and females (↓33%, both P < 0.032) via reduced (male: ↓31%, female: ↓35%, both P < 0.020), (male: 5.6 ± 0.5 vs . 4.0 ± 0.5, female: 6.4 ± 1.1 vs . 4.2 ± 0.6 mL O 2 min –1 100 g tissue –1 , P < 0.022) and the resulting is , with females also demonstrating a reduced (0.40 ± 0.07 vs . 0.30 ± 0.04 mL O 2 min –1 100 g tissue –1 , P < 0.042) and a greater GLI‐induced speeding of is fall (mean response time: Sex × Drug interaction, P = 0.026). Conversely, GLI did not impair the mixed gastrocnemius of F+OVX rats. Therefore, in patients taking sulphonylureas, these results support the potential for impaired vascular K ATP channel function to compromise muscle and therefore exercise tolerance. Such an effect, if present, would likely contribute to adverse cardiovascular events in premenopausal females more than males.
No takes yet. Share an insight, caveat, or question.
Colburn et al. (2021) studied this question. Glibenclamide superfusion vs. Baseline / Males / Ovariectomized females was evaluated on Skeletal muscle blood flow and interstitial O2 delivery-utilization matching (p=<0.032). Glibenclamide impaired skeletal muscle blood flow in male (↓28%) and female (↓33%) rats, with females also demonstrating impaired diffusive O2 transport and a faster fall in interstitial PO2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: